Prism Medico and Pharmacy Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Prism Medico and Pharmacy Ltd. on BSE

Load latest

Prism Medico and Pharmacy Ltd.

07 Apr 2025

17.38

-2.63%

Company Update

Prism Medico and Pharmacy Ltd - 512217 - Investor Complaints As Per Regulation 13(3) Of The …

BSE India

Dear Sir/Madam, Please find the attached statement of investor complaints as per Regulation 13(3) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st March, 2025.

pdf

Prism Medico and Pharmacy Ltd.

07 Apr 2025

17.38

-2.63%

Company Update

Prism Medico and Pharmacy Ltd - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Dear Sir/Madam, Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 please find the attached certificate for the quarter ended 31st March, 2025. Thanking You.

pdf

Prism Medico and Pharmacy Ltd.

01 Apr 2025

17.38

-2.63%

Corp. Note

Prism Medico and Pharmacy Ltd - 512217 - Compliance-57 (5) : intimation after the end of …

BSE India

Dear Sir, Please find the attached intimation under Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You.

pdf

Prism Medico and Pharmacy Ltd.

31 Mar 2025

17.38

-2.63%

Company Update

Prism Medico and Pharmacy Ltd - 512217 - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations …

BSE India

Dear Sir/Madam, Please find the attached intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015. Thanking You.

pdf

Prism Medico and Pharmacy Ltd.

31 Mar 2025

17.38

-2.63%

SAST

Prism Medico and Pharmacy Ltd - 512217 - Closure of Trading Window

BSE India

Dear Sir/Madam, Please find the attached intimation of closure of trading window. Thanking you.

pdf

Prism Medico and Pharmacy Ltd.

14 Feb 2025

17.38

-2.63%

Result

PRISM MEDICO AND PHARMACY LTD. - 512217 - Outcome Of The Board Meeting - Disclosure Under …

BSE India

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the board of directors at their meeting held today i.e. 14th February 2025 which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter-alia approved the following: The board considered and approved the Unaudited Standalone financial results of the company for the quarter ended 31st December 2024 along with the Limited Review Report duly signed by the auditors of the company.

pdf

Prism Medico and Pharmacy Ltd.

14 Feb 2025

17.38

-2.63%

Board Meeting

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 14th February, 2025) which commenced at 01:30 P.M. and concluded at 05:00 P.M. have inter alia approved the following: The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2024 along with the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.

pdf

Prism Medico and Pharmacy Ltd.

07 Feb 2025

17.38

-2.63%

Board Meeting

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for INTIMATION OF BOARD MEETING

BSE India

PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited(hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Friday, the 14th day of February, 2025 at 01:30 P.M. inter alia, to: - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December, 2024, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company.

pdf

Prism Medico and Pharmacy Ltd.

21 Jan 2025

17.38

-2.63%

Company Update

PRISM MEDICO AND PHARMACY LTD. - 512217 - Undertaking Of Functional Website.

BSE India

Dear Sir/Madam, With reference to the captioned subject, please the attached undertaking of functional website. You are requested to kindly take the same on record and acknowledge the receipt. Thanking You.

pdf

Prism Medico and Pharmacy Ltd.

18 Jan 2025

17.38

-2.63%

Company Update

PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The …

BSE India

Dear Sir/Madam, With reference to the captioned subject, report on investor complaints for the quarter ended 31st December, 2024 is attached herewith. You are requested to kindly take the same on record and oblige. Thanking You.

pdf

Is Prism Medico and Pharmacy Ltd. worth buying?

9 Votes:

Buy 77.78%

Sell 11.11%

Hold 11.11%